Safety and Tolerability of a Novel Anti-HER2 Antibody–Drug Conjugate (PF-06804103) in Patients with HER2-Expressing Solid Tumors: A Phase 1 Dose-Escalation Study
- Funda Meric-Bernstam
- , Emiliano Calvo
- , Keun Seok Lee
- , Victor Moreno
- , Yeon Hee Park
- , Sun Young Rha
- , Pavani Chalasani
- , Wei Zhong
- , Li Zhou
- , Steven Pirie-Shepherd
- , Abraham C.F. Leung
- , Giuseppe Curigliano
- University of Texas MD Anderson Cancer Center
- START Madrid-CIOCC
- National Cancer Center Korea
- Fundacion Jimenez Diaz University Hospital
- Yonsei University
- University of Arizona
- Pfizer
- IRCCS Istituto Europeo di Oncologia - Milano
- University of Milan
Research output: Contribution to journal › Article › peer-review
22
Link opens in a new tab
Scopus
citations